401 related articles for article (PubMed ID: 35571117)
1. Efficacy and Safety of Qili Qiangxin Capsule on Dilated Cardiomyopathy: A Systematic Review and Meta-Analysis of 35 Randomized Controlled Trials.
Wei J; Li B; Wang X; Li X; Hu Y; Qiao L; Zhou C; Yu P; Sang T; Zhu M; Wang Y
Front Pharmacol; 2022; 13():893602. PubMed ID: 35571117
[No Abstract] [Full Text] [Related]
2. Qili Qiangxin Capsule Combined With Sacubitril/Valsartan for HFrEF: A Systematic Review and Meta-Analysis.
Xiang Q; Wang M; Ding Y; Fan M; Tong H; Chen J; Yu P; Shen L; Chen X
Front Pharmacol; 2022; 13():832782. PubMed ID: 35444529
[No Abstract] [Full Text] [Related]
3. [Network Meta-analysis of 11 Chinese patent medicines in treatment of dilated cardiomyopathy].
Wang ZX; Wang H; Ban JF; Zhou YB; Qie R
Zhongguo Zhong Yao Za Zhi; 2023 Dec; 48(24):6778-6797. PubMed ID: 38212037
[TBL] [Abstract][Full Text] [Related]
4. Effect of
Han X; Yu T; Chen X; Du Z; Yu M; Xiong J
Front Pharmacol; 2024; 15():1345797. PubMed ID: 38283626
[No Abstract] [Full Text] [Related]
5. Efficacy and safety evaluation of Shenmai injections for dilated cardiomyopathy: A systematic review and meta-analysis of randomised controlled trials.
Wang Y; Liu Q; Kong Y; Zhong G; Wang D
Phytomedicine; 2023 Feb; 110():154630. PubMed ID: 36608499
[TBL] [Abstract][Full Text] [Related]
6. Clinical Efficacy of Qili Qiangxin Capsule Combined with Western Medicine in the Treatment of Chronic Heart Failure: A Systematic Review and Meta-Analysis.
Xu X; Yang Y; Zhou G; Du Z; Zhang X; Mao W; Cai H
Evid Based Complement Alternat Med; 2021; 2021():9761159. PubMed ID: 34408783
[TBL] [Abstract][Full Text] [Related]
7. Clinical effects of a standardized Chinese herbal remedy, Qili Qiangxin, as an adjuvant treatment in heart failure: systematic review and meta-analysis.
Sun J; Zhang K; Xiong WJ; Yang GY; Zhang YJ; Wang CC; Lai L; Han M; Ren J; Lewith G; Liu JP
BMC Complement Altern Med; 2016 Jul; 16():201. PubMed ID: 27402016
[TBL] [Abstract][Full Text] [Related]
8. [Comparative analysis of clinical effects according to syndrome differentiation of Qili Qiangxin Capsules on ischemic heart failure: Meta-analysis].
Sun YL; Ruan XF; Li YP; Wang XL
Zhongguo Zhong Yao Za Zhi; 2019 Nov; 44(22):4975-4984. PubMed ID: 31872608
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Chinese traditional patent medicines for heart failure with preserved ejection fraction: a Bayesian network meta-analysis of 64 randomized controlled trials.
Guo H; Zhu M; Yu R; Li X; Zhao Q
Front Cardiovasc Med; 2023; 10():1255940. PubMed ID: 38054101
[TBL] [Abstract][Full Text] [Related]
10. [Network Meta-analysis of Chinese patent medicine in treatment of heart failure with preserved ejection fraction].
Tian J; Xu BR; Xing ZY; Qiu BY; Si CY; Zhu MJ; Wang YX
Zhongguo Zhong Yao Za Zhi; 2024 Feb; 49(3):819-835. PubMed ID: 38621886
[TBL] [Abstract][Full Text] [Related]
11. Acupuncture treatment vs. cognitive rehabilitation for post-stroke cognitive impairment: A systematic review and meta-analysis of randomized controlled trials.
Liu Y; Chen F; Qin P; Zhao L; Li X; Han J; Ke Z; Zhu H; Wu B
Front Neurol; 2023; 14():1035125. PubMed ID: 36846126
[TBL] [Abstract][Full Text] [Related]
12. Effect of arotinolol on chronic heart failure: A systematic review and meta-analysis of randomized controlled trials.
Huang P; Song Q; Wang Y; Wang A; Guo L; Zhang H; Zhang Z; Ma X
Front Cardiovasc Med; 2022; 9():1071387. PubMed ID: 36588575
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive effect of Naoxintong capsule combined with Western medicine on coronary heart disease after percutaneous coronary intervention: a meta-analysis.
Yu L; Huang P; Wang M; Li Z; Cai H; Feng Y; Wu L; Peng W; Zeng J; Chen B
Front Pharmacol; 2024; 15():1274000. PubMed ID: 38590642
[TBL] [Abstract][Full Text] [Related]
14. Clinical effect of Danshen decoction in patients with heart failure: A systematic review and meta-analysis of randomized controlled trials.
Li Z; Liu M; Chen M; Luo G; Wu J; Mazhar M; Yang F; Zheng Y; Wu H; Wu Q; Yang S
PLoS One; 2023; 18(5):e0284877. PubMed ID: 37146072
[TBL] [Abstract][Full Text] [Related]
15. External therapy of traditional Chinese medicine for treating irritable bowel syndrome with diarrhea: A systematic review and meta-analysis.
Wei X; Wen Y; Wei Y; Liang X; Ma X; Zhang B; Tang X
Front Med (Lausanne); 2022; 9():940328. PubMed ID: 36017012
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of Shen Gui capsules for chronic heart failure: a systematic review and meta-analysis.
Yan J; Zhang C; Wang Y; Yan X; Jin L
Front Pharmacol; 2024; 15():1347828. PubMed ID: 38659585
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of L-Carnitine for Dilated Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials.
Weng Y; Zhang S; Huang W; Xie X; Ma Z; Fan Q
Biomed Res Int; 2021; 2021():9491615. PubMed ID: 33521132
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of Chinese herbal medicine in post-stroke epilepsy: a systematic review and meta-analysis.
Sun T; Wang K; Li L; Yan M; Wu J; Liu J
Front Pharmacol; 2023; 14():1286093. PubMed ID: 38074155
[No Abstract] [Full Text] [Related]
19. The efficacy and safety of Chinese herbal medicine as an add-on therapy for type 2 diabetes mellitus patients with carotid atherosclerosis: An updated meta-analysis of 27 randomized controlled trials.
Zhang Z; Leng Y; Chen Z; Fu X; Liang Q; Peng X; Xie H; Gao H; Xie C
Front Pharmacol; 2023; 14():1091718. PubMed ID: 37033624
[No Abstract] [Full Text] [Related]
20. Efficacy and safety of Shexiang Baoxin Pill for stable coronary artery disease: A systematic review and meta-analysis of 42 randomized controlled trials.
Wei J; Ma T; Zhou C; Hao P; Li B; Wang X; Yu R; Zhu M; Wang Y
Front Pharmacol; 2022; 13():1002713. PubMed ID: 36452225
[No Abstract] [Full Text] [Related]
[Next] [New Search]
